Evaluation of DeGIR registry data on endovascular treatment of cerebral vasospasm in Germany 2018–2021: an overview of the current care situation
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren · 01.11.2023 · 195 (11) · 1018-1026
DOI: 10.1055/a-2102-0129 ↗Kurz gefasst
Fachartikel in der Zeitschrift RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, erschienen am 01.11.2023. Verfasst von Alexander Neumann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroradiology, University Hospital Schleswig-Holstein, Campus Lübeck, Germany. Hauptthemen laut MEDLINE: Vasospasm, Intracranial, Subarachnoid Hemorrhage, Endovascular Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Background
Evaluation of endovascular therapies for cerebral vasospasm (CVS) documented in the DeGIR registry from 2018–2021 to analyse the current clinical care situation in Germany.
Methods
Retrospective analysis of the clinical and procedural data on endovascular spasm therapies (EST) documented anonymously in the DeGIR registry. We analysed: pre-interventional findings of CTP and consciousness; radiation dose applied, interventional-technical parameters (local medication, devices, angiographic result), post-interventional symptoms, complications and mortality.
Results
3584 patients received a total of 7628 EST (median age/patient: 53 [range: 13–100, IQR: 44–60], 68.2 % women) in 91 (2018), 92 (2019), 100 (2020) and 98 (2021) centres; 5388 (70.6 %) anterior circulation and 378 (5 %) posterior circulation (both involved in 1862 cases [24.4 %]). EST was performed once in 2125 cases (27.9 %), with a mean of 2.1 EST/patient. In 7476 times, purely medicated EST were carried out (nimodipine: 6835, papaverine: 401, nitroglycerin: 62, other drug not specified: 239; combinations: 90). Microcatheter infusions were documented in 1132 times (14.8 %). Balloon angioplasty (BA) (additional) was performed in 756 EST (9.9 %), other mechanical recanalisations in 154 cases (2 %) and stenting in 176 of the EST (2.3 %). The median dose area product during ET was 4069 cGycm² (drug: 4002/[+]BA: 8003 [p < 0.001]). At least 1 complication occurred in 95 of all procedures (1.2 %) (drug: 1.1 %/[+]BA: 4.2 % [p < 0.001]). Mortality associated with EST was 0.2 % (n = 18). After EST, overall improvement or elimination of CVS was found in 94.2 % of cases (drug: 93.8 %/[+]BA: 98.1 % [p < 0.001]). In a comparison of the locally applied drugs, papaverine eliminated CVS more frequently than nimodipine (p = 0.001).
Conclusion
EST have a moderate radiation exposure and can be performed with few complications. Purely medicated EST are predominantly performed, especially with nimodipine. With (additional) BA, radiation exposure, complication rates and angiographic results are higher or better. When considering drug EST alone, there is evidence for an advantage of papaverine over nimodipine, but a different group size has to be taken into account. In the analysis of EST, the DeGIR registry data are suitable for answering more specific questions, especially due to the large number of cases; for this purpose, further subgroupings should be sought in the data documentation. Key points: Citation Format
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuroradiology, University Hospital Schleswig-Holstein, Campus Lübeck, Germany.
- Institute of Diagnostic and Interventional Radiology, Neuroradiology and Nuclear Medicine, University Hospital Knappschaftskrankenhaus Bochum, Germany.
- Department of Neurosurgery, University Hospital Schleswig-Holstein, Campus Lübeck, Germany.
- Department of Diagnostic and Interventional Neuroradiology, University Hospital Augsburg, Germany.
ORCID-Profile: Alexander Neumann
Zitieren
APA
Neumann, A., Weber, W., Küchler, J., Schacht, H., Jensen-Kondering, U., Berlis, A., & Schramm, P. (2023). Evaluation of DeGIR registry data on endovascular treatment of cerebral vasospasm in Germany 2018–2021: an overview of the current care situation. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren, 195(11), 1018-1026. https://doi.org/10.1055/a-2102-0129
Vancouver
Neumann A, Weber W, Küchler J, Schacht H, Jensen-Kondering U, Berlis A, et al. Evaluation of DeGIR registry data on endovascular treatment of cerebral vasospasm in Germany 2018–2021: an overview of the current care situation. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 2023;195(11):1018-1026. doi:10.1055/a-2102-0129
BibTeX
@article{Neumann2023,
author = {Neumann, Alexander and Weber, Werner and Küchler, Jan and Schacht, Hannes and Jensen-Kondering, Ulf and Berlis, Ansgar and Schramm, Peter},
title = {Evaluation of DeGIR registry data on endovascular treatment of cerebral vasospasm in Germany 2018–2021: an overview of the current care situation},
journal = {RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren},
year = {2023},
volume = {195},
number = {11},
pages = {1018--1026},
doi = {10.1055/a-2102-0129}
}
EUVIMED